SCORE2-OP — 5/10-Year CVD Risk (Age ≥ 70)
SCORE2 for Older Persons — estimates 5-year and 10-year CVD risk in adults aged ≥ 70 years without established CVD.
Score interpretation
SCORE2-OP < 15%: Relatively lower risk. Balance treatment benefit vs. polypharmacy burden in older patients.
→ Lifestyle optimisation. Consider statin if not already prescribed and life expectancy adequate.
SCORE2-OP 15–29%: High risk. Statin therapy generally recommended if tolerated.
→ Statin therapy. BP management. Frailty assessment to guide treatment intensity.
SCORE2-OP ≥ 30%: Very high risk. Aggressive cardiovascular risk reduction as tolerated.
→ High-intensity statin (if tolerated). Aggressive BP control. Full cardiovascular medication review. Consider geriatric assessment.
Interpretation bands for the SCORE2-OP. Apply clinical judgement and local guidance.
References
- SCORE2-OP working group and ESC Cardiovascular Risk Collaboration. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons. Eur Heart J. 2021;42(25):2455-2467.
Related
Curated clinical cross-links plus same-class fallbacks.
- Framingham Risk Score · Cardiovascular Risk
- ACC/AHA Pooled Cohort Equations — ASCVD Risk · Cardiovascular Risk
- PREVENT Cardiovascular Risk Calculator (AHA/ACC 2023) · Cardiovascular Risk
- Reynolds Risk Score for Women · Cardiovascular Risk
- SCORE2 — 10-Year CVD Risk (Age 40–69) · Cardiovascular Risk
- SCORE2-Diabetes 10-Year CVD Risk in Type 2 Diabetes · Cardiovascular Risk
- Atorvastatin (CKD Cardiovascular Risk) · Cardiovascular Risk in CKD
- Icosapent Ethyl (Omega-3 — Cardiovascular Risk Reduction) · Omega-3 Fatty Acid (Purified EPA — Eicosapentaenoic Acid Ethyl Ester)
- Fluvastatin · HMG-CoA reductase inhibitor (statin)
- Pravastatin sodium · HMG-CoA reductase inhibitor (hydrophilic statin)
- Tenecteplase · Cardiovascular Emergency
- Tirofiban · Cardiovascular Emergency
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.